View : 869 Download: 0
Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial
- Title
- Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial
- Authors
- Kim, H.; Lee, Y.; Oh, Y. -M.; Rhee, C. K.; Kyung, S.; Chang, J.; Lee, W. -Y.; Kim, J. S.
- Ewha Authors
- 장중현
- SCOPUS Author ID
- 장중현
- Issue Date
- 2015
- Journal Title
- AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- ISSN
- 1073-449X
1535-4970
- Citation
- AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE vol. 191
- Publisher
- AMER THORACIC SOC
- Indexed
- SCIE; SCOPUS
- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML